{"transactions":[{"id":679034,"issuer":{"id":1907,"kind":"organization","name":"Veradermics, Inc","symbol":"MANE"},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"MONTANOVA CAPITAL, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":2,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See footnotes"}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":4,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Pre-Funded Warrants","published_at":"2026-08-21T22:11:27.000Z","date":"2026-08-20","kind":"other","planned":false,"acquired":false,"shares":151000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Notes are included on Exhibit 99.1."},{"field":"shares","element":"transactionShares","label":"F5","text":"Notes are included on Exhibit 99.1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Notes are included on Exhibit 99.1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Notes are included on Exhibit 99.1."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Notes are included on Exhibit 99.1."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F7","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Notes are included on Exhibit 99.1."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":151000},"source":{"system":"sec-edgar","filing":"0000899140-26-000947","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914026000947/form4.xml","form_type":"4"}},{"id":679033,"issuer":{"id":1907,"kind":"organization","name":"Veradermics, Inc","symbol":"MANE"},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"MONTANOVA CAPITAL, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":2,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See footnotes"}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":4,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Pre-Funded Warrants","published_at":"2026-08-21T22:11:27.000Z","date":"2026-08-20","kind":"other","planned":false,"acquired":false,"shares":149000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Notes are included on Exhibit 99.1."},{"field":"shares","element":"transactionShares","label":"F4","text":"Notes are included on Exhibit 99.1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Notes are included on Exhibit 99.1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Notes are included on Exhibit 99.1."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Notes are included on Exhibit 99.1."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F7","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Notes are included on Exhibit 99.1."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":149000},"source":{"system":"sec-edgar","filing":"0000899140-26-000947","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914026000947/form4.xml","form_type":"4"}},{"id":679032,"issuer":{"id":1907,"kind":"organization","name":"Veradermics, Inc","symbol":"MANE"},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"MONTANOVA CAPITAL, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":2,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See footnotes"}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":4,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, par value $0.00001 per share","published_at":"2026-08-21T22:11:27.000Z","date":"2026-08-20","kind":"other","planned":false,"acquired":true,"shares":151000,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Notes are included on Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Notes are included on Exhibit 99.1."}],"balance_after":612033,"source":{"system":"sec-edgar","filing":"0000899140-26-000947","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914026000947/form4.xml","form_type":"4"}},{"id":679031,"issuer":{"id":1907,"kind":"organization","name":"Veradermics, Inc","symbol":"MANE"},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"MONTANOVA CAPITAL, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":2,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See footnotes"}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":4,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, par value $0.00001 per share","published_at":"2026-08-21T22:11:27.000Z","date":"2026-08-20","kind":"other","planned":false,"acquired":true,"shares":149000,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Notes are included on Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Notes are included on Exhibit 99.1."}],"balance_after":3106937,"source":{"system":"sec-edgar","filing":"0000899140-26-000947","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914026000947/form4.xml","form_type":"4"}},{"id":679030,"issuer":{"id":1907,"kind":"organization","name":"Veradermics, Inc","symbol":"MANE"},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"MONTANOVA CAPITAL, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":2,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See footnotes"}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":4,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, par value $0.00001 per share","published_at":"2026-08-21T22:11:27.000Z","date":"2026-08-19","kind":"sale","planned":false,"acquired":false,"shares":59399,"price":107.25,"value":6370542.75,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Notes are included on Exhibit 99.1."}],"balance_after":461033,"source":{"system":"sec-edgar","filing":"0000899140-26-000947","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914026000947/form4.xml","form_type":"4"}},{"id":679029,"issuer":{"id":1907,"kind":"organization","name":"Veradermics, Inc","symbol":"MANE"},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"MONTANOVA CAPITAL, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":2,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See footnotes"}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":4,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, par value $0.00001 per share","published_at":"2026-08-21T22:11:27.000Z","date":"2026-08-19","kind":"sale","planned":false,"acquired":false,"shares":690601,"price":107.25,"value":74066957.25,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Notes are included on Exhibit 99.1."}],"balance_after":2957937,"source":{"system":"sec-edgar","filing":"0000899140-26-000947","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914026000947/form4.xml","form_type":"4"}},{"id":792104,"issuer":{"id":1907,"kind":"organization","name":"Veradermics, Inc","symbol":"MANE"},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":2,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"other":true,"other_text":"See footnotes"}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":4,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true}}],"security":"Pre-Funded Warrants","published_at":"2026-05-06T01:37:59.000Z","date":"2026-05-01","kind":"grant","planned":false,"acquired":true,"shares":151000,"price":99.9999,"value":15099984.9,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Notes are included on Exhibit 99.1."},{"field":"shares","element":"transactionShares","label":"F3","text":"Notes are included on Exhibit 99.1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Notes are included on Exhibit 99.1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Notes are included on Exhibit 99.1."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Notes are included on Exhibit 99.1."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F5","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Notes are included on Exhibit 99.1."}],"balance_after":151000,"derivative":{"underlying":"Common stock","underlying_shares":151000},"source":{"system":"sec-edgar","filing":"0000899140-26-000415","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914026000415/form4.xml","form_type":"4"}},{"id":792103,"issuer":{"id":1907,"kind":"organization","name":"Veradermics, Inc","symbol":"MANE"},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":2,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"other":true,"other_text":"See footnotes"}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":4,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true}}],"security":"Pre-Funded Warrants","published_at":"2026-05-06T01:37:59.000Z","date":"2026-05-01","kind":"grant","planned":false,"acquired":true,"shares":149000,"price":99.9999,"value":14899985.1,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Notes are included on Exhibit 99.1."},{"field":"shares","element":"transactionShares","label":"F2","text":"Notes are included on Exhibit 99.1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Notes are included on Exhibit 99.1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Notes are included on Exhibit 99.1."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Notes are included on Exhibit 99.1."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F5","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Notes are included on Exhibit 99.1."}],"balance_after":149000,"derivative":{"underlying":"Common stock","underlying_shares":149000},"source":{"system":"sec-edgar","filing":"0000899140-26-000415","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914026000415/form4.xml","form_type":"4"}},{"id":914675,"issuer":{"id":1907,"kind":"organization","name":"Veradermics, Inc","symbol":"MANE"},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":2,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":4,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common stock, par value $0.00001 per share","published_at":"2026-02-09T23:28:51.000Z","date":"2026-02-06","kind":"purchase","planned":false,"acquired":true,"shares":19338,"price":36.55,"value":706803.9,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F20","text":"Notes are included on Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F20","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F20","text":"Notes are included on Exhibit 99.1."}],"balance_after":520453,"source":{"system":"sec-edgar","filing":"0000899140-26-000140","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914026000140/form4.xml","form_type":"4"}},{"id":914674,"issuer":{"id":1907,"kind":"organization","name":"Veradermics, Inc","symbol":"MANE"},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":2,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":4,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common stock, par value $0.00001 per share","published_at":"2026-02-09T23:28:51.000Z","date":"2026-02-06","kind":"purchase","planned":false,"acquired":true,"shares":11183,"price":35.97,"value":402252.51,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F19","text":"Notes are included on Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F19","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F19","text":"Notes are included on Exhibit 99.1."}],"balance_after":501115,"source":{"system":"sec-edgar","filing":"0000899140-26-000140","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914026000140/form4.xml","form_type":"4"}},{"id":914673,"issuer":{"id":1907,"kind":"organization","name":"Veradermics, Inc","symbol":"MANE"},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":2,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":4,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common stock, par value $0.00001 per share","published_at":"2026-02-09T23:28:51.000Z","date":"2026-02-05","kind":"purchase","planned":false,"acquired":true,"shares":16563,"price":39.8,"value":659207.4,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F18","text":"Notes are included on Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F18","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F18","text":"Notes are included on Exhibit 99.1."}],"balance_after":489932,"source":{"system":"sec-edgar","filing":"0000899140-26-000140","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914026000140/form4.xml","form_type":"4"}},{"id":914672,"issuer":{"id":1907,"kind":"organization","name":"Veradermics, Inc","symbol":"MANE"},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":2,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":4,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common stock, par value $0.00001 per share","published_at":"2026-02-09T23:28:51.000Z","date":"2026-02-05","kind":"purchase","planned":false,"acquired":true,"shares":17835,"price":38.67,"value":689679.45,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F17","text":"Notes are included on Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F17","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F17","text":"Notes are included on Exhibit 99.1."}],"balance_after":473369,"source":{"system":"sec-edgar","filing":"0000899140-26-000140","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914026000140/form4.xml","form_type":"4"}},{"id":914671,"issuer":{"id":1907,"kind":"organization","name":"Veradermics, Inc","symbol":"MANE"},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":2,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":4,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common stock, par value $0.00001 per share","published_at":"2026-02-09T23:28:51.000Z","date":"2026-02-05","kind":"purchase","planned":false,"acquired":true,"shares":38771,"price":37.63,"value":1458952.73,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F16","text":"Notes are included on Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F16","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F16","text":"Notes are included on Exhibit 99.1."}],"balance_after":455534,"source":{"system":"sec-edgar","filing":"0000899140-26-000140","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914026000140/form4.xml","form_type":"4"}},{"id":914670,"issuer":{"id":1907,"kind":"organization","name":"Veradermics, Inc","symbol":"MANE"},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":2,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":4,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common stock, par value $0.00001 per share","published_at":"2026-02-09T23:28:51.000Z","date":"2026-02-05","kind":"purchase","planned":false,"acquired":true,"shares":19199,"price":36.93,"value":709019.07,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F15","text":"Notes are included on Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F15","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F15","text":"Notes are included on Exhibit 99.1."}],"balance_after":416763,"source":{"system":"sec-edgar","filing":"0000899140-26-000140","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914026000140/form4.xml","form_type":"4"}},{"id":914669,"issuer":{"id":1907,"kind":"organization","name":"Veradermics, Inc","symbol":"MANE"},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":2,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":4,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common stock, par value $0.00001 per share","published_at":"2026-02-09T23:28:51.000Z","date":"2026-02-05","kind":"purchase","planned":false,"acquired":true,"shares":3832,"price":36.07,"value":138220.24,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F14","text":"Notes are included on Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F14","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F14","text":"Notes are included on Exhibit 99.1."}],"balance_after":397564,"source":{"system":"sec-edgar","filing":"0000899140-26-000140","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914026000140/form4.xml","form_type":"4"}},{"id":914668,"issuer":{"id":1907,"kind":"organization","name":"Veradermics, Inc","symbol":"MANE"},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":2,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":4,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common stock, par value $0.00001 per share","published_at":"2026-02-09T23:28:51.000Z","date":"2026-02-04","kind":"purchase","planned":false,"acquired":true,"shares":3178,"price":38.9,"value":123624.2,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F13","text":"Notes are included on Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F13","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F13","text":"Notes are included on Exhibit 99.1."}],"balance_after":393732,"source":{"system":"sec-edgar","filing":"0000899140-26-000140","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914026000140/form4.xml","form_type":"4"}},{"id":914667,"issuer":{"id":1907,"kind":"organization","name":"Veradermics, Inc","symbol":"MANE"},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":2,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":4,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common stock, par value $0.00001 per share","published_at":"2026-02-09T23:28:51.000Z","date":"2026-02-04","kind":"purchase","planned":false,"acquired":true,"shares":4453,"price":38.09,"value":169614.77,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F12","text":"Notes are included on Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F12","text":"Notes are included on Exhibit 99.1."}],"balance_after":390554,"source":{"system":"sec-edgar","filing":"0000899140-26-000140","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914026000140/form4.xml","form_type":"4"}},{"id":914666,"issuer":{"id":1907,"kind":"organization","name":"Veradermics, Inc","symbol":"MANE"},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":2,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":4,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common stock, par value $0.00001 per share","published_at":"2026-02-09T23:28:51.000Z","date":"2026-02-04","kind":"purchase","planned":false,"acquired":true,"shares":9168,"price":37.11,"value":340224.48,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F11","text":"Notes are included on Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F11","text":"Notes are included on Exhibit 99.1."}],"balance_after":386101,"source":{"system":"sec-edgar","filing":"0000899140-26-000140","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914026000140/form4.xml","form_type":"4"}},{"id":914665,"issuer":{"id":1907,"kind":"organization","name":"Veradermics, Inc","symbol":"MANE"},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":2,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":4,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common stock, par value $0.00001 per share","published_at":"2026-02-09T23:28:51.000Z","date":"2026-02-04","kind":"purchase","planned":false,"acquired":true,"shares":2519,"price":36.27,"value":91364.13,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F10","text":"Notes are included on Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"Notes are included on Exhibit 99.1."}],"balance_after":376933,"source":{"system":"sec-edgar","filing":"0000899140-26-000140","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914026000140/form4.xml","form_type":"4"}},{"id":914664,"issuer":{"id":1907,"kind":"organization","name":"Veradermics, Inc","symbol":"MANE"},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":2,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":4,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common stock, par value $0.00001 per share","published_at":"2026-02-09T23:28:51.000Z","date":"2026-02-04","kind":"purchase","planned":false,"acquired":true,"shares":1835,"price":34.74,"value":63747.9,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F9","text":"Notes are included on Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"Notes are included on Exhibit 99.1."}],"balance_after":374414,"source":{"system":"sec-edgar","filing":"0000899140-26-000140","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914026000140/form4.xml","form_type":"4"}},{"id":914663,"issuer":{"id":1907,"kind":"organization","name":"Veradermics, Inc","symbol":"MANE"},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":2,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":4,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common stock, par value $0.00001 per share","published_at":"2026-02-09T23:28:51.000Z","date":"2026-02-04","kind":"purchase","planned":false,"acquired":true,"shares":1720,"price":34.25,"value":58910.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F8","text":"Notes are included on Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Notes are included on Exhibit 99.1."}],"balance_after":372579,"source":{"system":"sec-edgar","filing":"0000899140-26-000140","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914026000140/form4.xml","form_type":"4"}},{"id":914662,"issuer":{"id":1907,"kind":"organization","name":"Veradermics, Inc","symbol":"MANE"},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":2,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":4,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common stock, par value $0.00001 per share","published_at":"2026-02-09T23:28:51.000Z","date":"2026-02-04","kind":"purchase","planned":false,"acquired":true,"shares":18489,"price":38.9,"value":719222.1,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F7","text":"Notes are included on Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Notes are included on Exhibit 99.1."}],"balance_after":3648538,"source":{"system":"sec-edgar","filing":"0000899140-26-000140","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914026000140/form4.xml","form_type":"4"}},{"id":914661,"issuer":{"id":1907,"kind":"organization","name":"Veradermics, Inc","symbol":"MANE"},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":2,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":4,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common stock, par value $0.00001 per share","published_at":"2026-02-09T23:28:51.000Z","date":"2026-02-04","kind":"purchase","planned":false,"acquired":true,"shares":25908,"price":38.09,"value":986835.72,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"Notes are included on Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Notes are included on Exhibit 99.1."}],"balance_after":3630049,"source":{"system":"sec-edgar","filing":"0000899140-26-000140","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914026000140/form4.xml","form_type":"4"}},{"id":914660,"issuer":{"id":1907,"kind":"organization","name":"Veradermics, Inc","symbol":"MANE"},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":2,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":4,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common stock, par value $0.00001 per share","published_at":"2026-02-09T23:28:51.000Z","date":"2026-02-04","kind":"purchase","planned":false,"acquired":true,"shares":53344,"price":37.11,"value":1979595.84,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Notes are included on Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Notes are included on Exhibit 99.1."}],"balance_after":3604141,"source":{"system":"sec-edgar","filing":"0000899140-26-000140","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914026000140/form4.xml","form_type":"4"}},{"id":914659,"issuer":{"id":1907,"kind":"organization","name":"Veradermics, Inc","symbol":"MANE"},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":2,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":4,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common stock, par value $0.00001 per share","published_at":"2026-02-09T23:28:51.000Z","date":"2026-02-04","kind":"purchase","planned":false,"acquired":true,"shares":14659,"price":36.27,"value":531681.93,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Notes are included on Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Notes are included on Exhibit 99.1."}],"balance_after":3550797,"source":{"system":"sec-edgar","filing":"0000899140-26-000140","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914026000140/form4.xml","form_type":"4"}},{"id":914658,"issuer":{"id":1907,"kind":"organization","name":"Veradermics, Inc","symbol":"MANE"},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":2,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":4,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common stock, par value $0.00001 per share","published_at":"2026-02-09T23:28:51.000Z","date":"2026-02-04","kind":"purchase","planned":false,"acquired":true,"shares":10676,"price":34.74,"value":370884.24,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Notes are included on Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Notes are included on Exhibit 99.1."}],"balance_after":3536138,"source":{"system":"sec-edgar","filing":"0000899140-26-000140","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914026000140/form4.xml","form_type":"4"}},{"id":914657,"issuer":{"id":1907,"kind":"organization","name":"Veradermics, Inc","symbol":"MANE"},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":2,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":4,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common stock, par value $0.00001 per share","published_at":"2026-02-09T23:28:51.000Z","date":"2026-02-04","kind":"purchase","planned":false,"acquired":true,"shares":10004,"price":34.25,"value":342637.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Notes are included on Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Notes are included on Exhibit 99.1."}],"balance_after":3525462,"source":{"system":"sec-edgar","filing":"0000899140-26-000140","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914026000140/form4.xml","form_type":"4"}},{"id":958444,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":2,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":4,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common stock, par value $0.0001 per share","published_at":"2025-12-30T00:31:28.000Z","date":"2025-12-29","kind":"purchase","planned":false,"acquired":true,"shares":11587,"price":13.44,"value":155729.28,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F7","text":"Notes are included on Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Notes are included on Exhibit 99.1."}],"balance_after":1848156,"source":{"system":"sec-edgar","filing":"0000899140-25-001479","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914025001479/form4.xml","form_type":"4"}},{"id":958443,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":2,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":4,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common stock, par value $0.0001 per share","published_at":"2025-12-30T00:31:28.000Z","date":"2025-12-29","kind":"purchase","planned":false,"acquired":true,"shares":65800,"price":13.44,"value":884352.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"Notes are included on Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Notes are included on Exhibit 99.1."}],"balance_after":9700195,"source":{"system":"sec-edgar","filing":"0000899140-25-001479","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914025001479/form4.xml","form_type":"4"}},{"id":958442,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":2,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":4,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common stock, par value $0.0001 per share","published_at":"2025-12-30T00:31:28.000Z","date":"2025-12-26","kind":"purchase","planned":false,"acquired":true,"shares":2516,"price":13.1,"value":32959.6,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Notes are included on Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Notes are included on Exhibit 99.1."}],"balance_after":1836569,"source":{"system":"sec-edgar","filing":"0000899140-25-001479","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914025001479/form4.xml","form_type":"4"}},{"id":958441,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":2,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":4,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common stock, par value $0.0001 per share","published_at":"2025-12-30T00:31:28.000Z","date":"2025-12-26","kind":"purchase","planned":false,"acquired":true,"shares":14320,"price":13.1,"value":187592.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Notes are included on Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Notes are included on Exhibit 99.1."}],"balance_after":9634395,"source":{"system":"sec-edgar","filing":"0000899140-25-001479","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914025001479/form4.xml","form_type":"4"}},{"id":958440,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":2,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":4,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common stock, par value $0.0001 per share","published_at":"2025-12-30T00:31:28.000Z","date":"2025-12-23","kind":"purchase","planned":false,"acquired":true,"shares":7400,"price":12.85,"value":95090.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Notes are included on Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Notes are included on Exhibit 99.1."}],"balance_after":1834053,"source":{"system":"sec-edgar","filing":"0000899140-25-001479","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914025001479/form4.xml","form_type":"4"}},{"id":958439,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":2,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":4,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common stock, par value $0.0001 per share","published_at":"2025-12-30T00:31:28.000Z","date":"2025-12-23","kind":"purchase","planned":false,"acquired":true,"shares":42600,"price":12.85,"value":547410.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Notes are included on Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Notes are included on Exhibit 99.1."}],"balance_after":9620075,"source":{"system":"sec-edgar","filing":"0000899140-25-001479","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914025001479/form4.xml","form_type":"4"}},{"id":961233,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":2,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":4,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common stock, par value $0.0001 per share","published_at":"2025-12-23T00:45:03.000Z","date":"2025-12-22","kind":"purchase","planned":false,"acquired":true,"shares":2892,"price":12.08,"value":34935.36,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F7","text":"Notes are included on Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Notes are included on Exhibit 99.1."}],"balance_after":1826653,"source":{"system":"sec-edgar","filing":"0000899140-25-001459","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914025001459/form4.xml","form_type":"4"}},{"id":961232,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":2,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":4,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common stock, par value $0.0001 per share","published_at":"2025-12-23T00:45:03.000Z","date":"2025-12-22","kind":"purchase","planned":false,"acquired":true,"shares":16650,"price":12.08,"value":201132.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"Notes are included on Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Notes are included on Exhibit 99.1."}],"balance_after":9577475,"source":{"system":"sec-edgar","filing":"0000899140-25-001459","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914025001459/form4.xml","form_type":"4"}},{"id":961231,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":2,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":4,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common stock, par value $0.0001 per share","published_at":"2025-12-23T00:45:03.000Z","date":"2025-12-19","kind":"purchase","planned":false,"acquired":true,"shares":2434,"price":11.48,"value":27942.32,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Notes are included on Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Notes are included on Exhibit 99.1."}],"balance_after":1823761,"source":{"system":"sec-edgar","filing":"0000899140-25-001459","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914025001459/form4.xml","form_type":"4"}},{"id":961230,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":2,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":4,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common stock, par value $0.0001 per share","published_at":"2025-12-23T00:45:03.000Z","date":"2025-12-19","kind":"purchase","planned":false,"acquired":true,"shares":13950,"price":11.48,"value":160146.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Notes are included on Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Notes are included on Exhibit 99.1."}],"balance_after":9560825,"source":{"system":"sec-edgar","filing":"0000899140-25-001459","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914025001459/form4.xml","form_type":"4"}},{"id":961229,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":2,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":4,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common stock, par value $0.0001 per share","published_at":"2025-12-23T00:45:03.000Z","date":"2025-12-18","kind":"purchase","planned":false,"acquired":true,"shares":1515,"price":11.24,"value":17028.6,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Notes are included on Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Notes are included on Exhibit 99.1."}],"balance_after":1821327,"source":{"system":"sec-edgar","filing":"0000899140-25-001459","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914025001459/form4.xml","form_type":"4"}},{"id":961228,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":2,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":4,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common stock, par value $0.0001 per share","published_at":"2025-12-23T00:45:03.000Z","date":"2025-12-18","kind":"purchase","planned":false,"acquired":true,"shares":8700,"price":11.24,"value":97788.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Notes are included on Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Notes are included on Exhibit 99.1."}],"balance_after":9546875,"source":{"system":"sec-edgar","filing":"0000899140-25-001459","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914025001459/form4.xml","form_type":"4"}},{"id":1003916,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":2,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":4,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"ten_percent_owner":true}}],"security":"Common stock, par value $0.0001 per share","published_at":"2025-11-11T02:51:33.000Z","date":"2025-11-07","kind":"purchase","planned":false,"acquired":true,"shares":751111,"price":13.5,"value":10139998.5,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Notes are included on Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Notes are included on Exhibit 99.1."}],"balance_after":1819812,"source":{"system":"sec-edgar","filing":"0000899140-25-001256","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914025001256/form4.xml","form_type":"4"}},{"id":1003915,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":2,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":4,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"ten_percent_owner":true}}],"security":"Common stock, par value $0.0001 per share","published_at":"2025-11-11T02:51:33.000Z","date":"2025-11-07","kind":"purchase","planned":false,"acquired":true,"shares":730370,"price":13.5,"value":9859995.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Notes are included on Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Notes are included on Exhibit 99.1."}],"balance_after":9538175,"source":{"system":"sec-edgar","filing":"0000899140-25-001256","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914025001256/form4.xml","form_type":"4"}},{"id":1184034,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":2,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":4,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"ten_percent_owner":true}}],"security":"Common stock, par value $0.0001 per share","published_at":"2025-04-02T20:37:02.000Z","date":"2025-03-31","kind":"purchase","planned":false,"acquired":true,"shares":670,"price":13.22,"value":8857.4,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Notes are included on Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Notes are included on Exhibit 99.1."}],"balance_after":1068701,"source":{"system":"sec-edgar","filing":"0000899140-25-000486","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914025000486/form4.xml","form_type":"4"}},{"id":1184033,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":2,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":4,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"ten_percent_owner":true}}],"security":"Common stock, par value $0.0001 per share","published_at":"2025-04-02T20:37:02.000Z","date":"2025-03-31","kind":"purchase","planned":false,"acquired":true,"shares":5057,"price":13.22,"value":66853.54,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Notes are included on Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Notes are included on Exhibit 99.1."}],"balance_after":8807805,"source":{"system":"sec-edgar","filing":"0000899140-25-000486","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914025000486/form4.xml","form_type":"4"}},{"id":1184032,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":2,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":4,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"ten_percent_owner":true}}],"security":"Common stock, par value $0.0001 per share","published_at":"2025-04-02T20:37:02.000Z","date":"2025-03-31","kind":"purchase","planned":false,"acquired":true,"shares":1267,"price":12.63,"value":16002.21,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Notes are included on Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Notes are included on Exhibit 99.1."}],"balance_after":1068031,"source":{"system":"sec-edgar","filing":"0000899140-25-000486","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914025000486/form4.xml","form_type":"4"}},{"id":1184031,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":2,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":4,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"ten_percent_owner":true}}],"security":"Common stock, par value $0.0001 per share","published_at":"2025-04-02T20:37:02.000Z","date":"2025-03-31","kind":"purchase","planned":false,"acquired":true,"shares":9503,"price":12.63,"value":120022.89,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Notes are included on Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Notes are included on Exhibit 99.1."}],"balance_after":8802748,"source":{"system":"sec-edgar","filing":"0000899140-25-000486","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914025000486/form4.xml","form_type":"4"}},{"id":1188970,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":2,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":4,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"ten_percent_owner":true}}],"security":"Common stock, par value $0.0001 per share","published_at":"2025-03-28T20:51:41.000Z","date":"2025-03-26","kind":"purchase","planned":false,"acquired":true,"shares":106200,"price":13,"value":1380600.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Notes are included on Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Notes are included on Exhibit 99.1."}],"balance_after":1066764,"source":{"system":"sec-edgar","filing":"0000899140-25-000479","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914025000479/form4.xml","form_type":"4"}},{"id":1188969,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":2,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":4,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"ten_percent_owner":true}}],"security":"Common stock, par value $0.0001 per share","published_at":"2025-03-28T20:51:41.000Z","date":"2025-03-26","kind":"purchase","planned":false,"acquired":true,"shares":793800,"price":13,"value":10319400.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Notes are included on Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Notes are included on Exhibit 99.1."}],"balance_after":8793245,"source":{"system":"sec-edgar","filing":"0000899140-25-000479","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914025000479/form4.xml","form_type":"4"}},{"id":1321984,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":2,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":4,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"ten_percent_owner":true}}],"security":"Common stock, par value $0.0001 per share","published_at":"2024-12-26T21:28:03.000Z","date":"2024-12-24","kind":"purchase","planned":false,"acquired":true,"shares":2288,"price":11.25,"value":25740.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Notes are included on Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Notes are included on Exhibit 99.1."}],"balance_after":960554,"source":{"system":"sec-edgar","filing":"0000899140-24-001385","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914024001385/form4.xml","form_type":"4"}},{"id":1321983,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":2,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":4,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"ten_percent_owner":true}}],"security":"Common stock, par value $0.0001 per share","published_at":"2024-12-26T21:28:03.000Z","date":"2024-12-24","kind":"purchase","planned":false,"acquired":true,"shares":17730,"price":11.25,"value":199462.5,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Notes are included on Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Notes are included on Exhibit 99.1."}],"balance_after":7999455,"source":{"system":"sec-edgar","filing":"0000899140-24-001385","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914024001385/form4.xml","form_type":"4"}},{"id":1321982,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":2,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":4,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"ten_percent_owner":true}}],"security":"Common stock, par value $0.0001 per share","published_at":"2024-12-26T21:28:03.000Z","date":"2024-12-23","kind":"purchase","planned":false,"acquired":true,"shares":3142,"price":10.98,"value":34499.16,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Notes are included on Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Notes are included on Exhibit 99.1."}],"balance_after":958266,"source":{"system":"sec-edgar","filing":"0000899140-24-001385","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914024001385/form4.xml","form_type":"4"}},{"id":1321981,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":2,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":4,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"ten_percent_owner":true}}],"security":"Common stock, par value $0.0001 per share","published_at":"2024-12-26T21:28:03.000Z","date":"2024-12-23","kind":"purchase","planned":false,"acquired":true,"shares":24360,"price":10.98,"value":267472.8,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Notes are included on Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Notes are included on Exhibit 99.1."}],"balance_after":7981725,"source":{"system":"sec-edgar","filing":"0000899140-24-001385","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914024001385/form4.xml","form_type":"4"}},{"id":1341847,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":2,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":4,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"ten_percent_owner":true}}],"security":"Common stock, par value $0.0001 per share","published_at":"2024-12-05T21:36:38.000Z","date":"2024-12-03","kind":"purchase","planned":false,"acquired":true,"shares":4810,"price":9.6,"value":46176.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Notes are included on Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Notes are included on Exhibit 99.1."}],"balance_after":955124,"source":{"system":"sec-edgar","filing":"0000899140-24-001318","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914024001318/form4.xml","form_type":"4"}},{"id":1341846,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":2,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":4,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"ten_percent_owner":true}}],"security":"Common stock, par value $0.0001 per share","published_at":"2024-12-05T21:36:38.000Z","date":"2024-12-03","kind":"purchase","planned":false,"acquired":true,"shares":37190,"price":9.6,"value":357024.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Notes are included on Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Notes are included on Exhibit 99.1."}],"balance_after":7957365,"source":{"system":"sec-edgar","filing":"0000899140-24-001318","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914024001318/form4.xml","form_type":"4"}},{"id":1356067,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":2,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":4,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"ten_percent_owner":true}}],"security":"Common stock, par value $0.0001 per share","published_at":"2024-11-21T21:24:23.000Z","date":"2024-11-20","kind":"purchase","planned":false,"acquired":true,"shares":3076,"price":10.22,"value":31436.72,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Notes are included on Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Notes are included on Exhibit 99.1."}],"balance_after":950314,"source":{"system":"sec-edgar","filing":"0000899140-24-001299","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914024001299/form4.xml","form_type":"4"}},{"id":1356066,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":2,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":4,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"ten_percent_owner":true}}],"security":"Common stock, par value $0.0001 per share","published_at":"2024-11-21T21:24:23.000Z","date":"2024-11-20","kind":"purchase","planned":false,"acquired":true,"shares":24360,"price":10.22,"value":248959.2,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Notes are included on Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Notes are included on Exhibit 99.1."}],"balance_after":7920175,"source":{"system":"sec-edgar","filing":"0000899140-24-001299","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914024001299/form4.xml","form_type":"4"}},{"id":1356065,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":2,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":4,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"ten_percent_owner":true}}],"security":"Common stock, par value $0.0001 per share","published_at":"2024-11-21T21:24:23.000Z","date":"2024-11-19","kind":"purchase","planned":false,"acquired":true,"shares":1570,"price":9.73,"value":15276.1,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Notes are included on Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Notes are included on Exhibit 99.1."}],"balance_after":947238,"source":{"system":"sec-edgar","filing":"0000899140-24-001299","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914024001299/form4.xml","form_type":"4"}},{"id":1356064,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":2,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":4,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"ten_percent_owner":true}}],"security":"Common stock, par value $0.0001 per share","published_at":"2024-11-21T21:24:23.000Z","date":"2024-11-19","kind":"purchase","planned":false,"acquired":true,"shares":12430,"price":9.73,"value":120943.9,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Notes are included on Exhibit 99.1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Notes are included on Exhibit 99.1."}],"balance_after":7895815,"source":{"system":"sec-edgar","filing":"0000899140-24-001299","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914024001299/form4.xml","form_type":"4"}},{"id":1398023,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":2,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":4,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Pre-Funded Warrants","published_at":"2024-09-30T21:17:45.000Z","date":"2024-09-26","kind":"other","planned":false,"acquired":false,"shares":148210,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Notes are included on Exhibit 99.1."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F6","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Notes are included on Exhibit 99.1."}],"balance_after":428137,"derivative":{"exercise_price":0.0001,"exercise_date":"2023-08-11","underlying":"Common Stock","underlying_shares":576347},"source":{"system":"sec-edgar","filing":"0000899140-24-001042","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914024001042/form4.xml","form_type":"4"}},{"id":1398022,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":2,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":4,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Warrants","published_at":"2024-09-30T21:17:45.000Z","date":"2024-09-26","kind":"other","planned":false,"acquired":false,"shares":576347,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F5","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Notes are included on Exhibit 99.1."}],"balance_after":0,"derivative":{"exercise_price":3.86,"exercise_date":"2023-08-11","expiration_date":"2028-08-11","underlying":"Common Stock","underlying_shares":576347},"source":{"system":"sec-edgar","filing":"0000899140-24-001042","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914024001042/form4.xml","form_type":"4"}},{"id":1398021,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":2,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":4,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Pre-Funded Warrants","published_at":"2024-09-30T21:17:45.000Z","date":"2024-09-26","kind":"other","planned":false,"acquired":false,"shares":1219970,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Notes are included on Exhibit 99.1."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Notes are included on Exhibit 99.1."}],"balance_after":3385030,"derivative":{"exercise_price":0.0001,"exercise_date":"2023-08-11","underlying":"Common Stock","underlying_shares":4605000},"source":{"system":"sec-edgar","filing":"0000899140-24-001042","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914024001042/form4.xml","form_type":"4"}},{"id":1398020,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":2,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":4,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Warrants","published_at":"2024-09-30T21:17:45.000Z","date":"2024-09-26","kind":"other","planned":false,"acquired":false,"shares":4605000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Notes are included on Exhibit 99.1."}],"balance_after":0,"derivative":{"exercise_price":3.86,"exercise_date":"2023-08-11","expiration_date":"2028-08-11","underlying":"Common Stock","underlying_shares":4605000},"source":{"system":"sec-edgar","filing":"0000899140-24-001042","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914024001042/form4.xml","form_type":"4"}},{"id":1398019,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":2,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":4,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Series 2 Common Warrants","published_at":"2024-09-30T21:17:45.000Z","date":"2024-09-26","kind":"other","planned":false,"acquired":false,"shares":10000000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Notes are included on Exhibit 99.1."}],"balance_after":0,"derivative":{"exercise_price":1.9299,"exercise_date":"2022-12-09","expiration_date":"2027-12-09","underlying":"Common Stock","underlying_shares":588236},"source":{"system":"sec-edgar","filing":"0000899140-24-001042","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914024001042/form4.xml","form_type":"4"}},{"id":1398018,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":2,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":4,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common stock, par value $0.0001 per share","published_at":"2024-09-30T21:17:45.000Z","date":"2024-09-26","kind":"other","planned":false,"acquired":true,"shares":148210,"price":0.0001,"value":14.821,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Notes are included on Exhibit 99.1."}],"balance_after":945668,"source":{"system":"sec-edgar","filing":"0000899140-24-001042","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914024001042/form4.xml","form_type":"4"}},{"id":1398017,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":2,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":4,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common stock, par value $0.0001 per share","published_at":"2024-09-30T21:17:45.000Z","date":"2024-09-26","kind":"other","planned":false,"acquired":true,"shares":576347,"price":3.86,"value":2224699.42,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Notes are included on Exhibit 99.1."}],"balance_after":797458,"source":{"system":"sec-edgar","filing":"0000899140-24-001042","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914024001042/form4.xml","form_type":"4"}},{"id":1398016,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":2,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":4,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common stock, par value $0.0001 per share","published_at":"2024-09-30T21:17:45.000Z","date":"2024-09-26","kind":"other","planned":false,"acquired":true,"shares":1219970,"price":0.0001,"value":121.997,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Notes are included on Exhibit 99.1."}],"balance_after":7883385,"source":{"system":"sec-edgar","filing":"0000899140-24-001042","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914024001042/form4.xml","form_type":"4"}},{"id":1398015,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":2,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":4,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common stock, par value $0.0001 per share","published_at":"2024-09-30T21:17:45.000Z","date":"2024-09-26","kind":"other","planned":false,"acquired":true,"shares":4605000,"price":3.86,"value":17775300.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Notes are included on Exhibit 99.1."}],"balance_after":6663415,"source":{"system":"sec-edgar","filing":"0000899140-24-001042","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914024001042/form4.xml","form_type":"4"}},{"id":1398014,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":20921,"kind":"person","name":"MONTANOVA CAPITAL, LLC","position":1,"cik":"0001569064","reported_name":"SUVRETTA CAPITAL MANAGEMENT, LLC","relationship":{"director":true,"ten_percent_owner":true}},{"id":20924,"kind":"person","name":"Averill Madison Master Fund, Ltd.","position":2,"cik":"0002021243","reported_name":"Averill Madison Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20923,"kind":"person","name":"Averill Master Fund, Ltd.","position":3,"cik":"0001939329","reported_name":"Averill Master Fund, Ltd.","relationship":{"director":true,"ten_percent_owner":true}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":4,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common stock, par value $0.0001 per share","published_at":"2024-09-30T21:17:45.000Z","date":"2024-09-26","kind":"other","planned":false,"acquired":true,"shares":588236,"price":1.9299,"value":1135236.6564,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Notes are included on Exhibit 99.1."}],"balance_after":2058415,"source":{"system":"sec-edgar","filing":"0000899140-24-001042","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2021243/000089914024001042/form4.xml","form_type":"4"}},{"id":1928913,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":20922,"kind":"person","name":"Cowen Aaron","position":1,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"ten_percent_owner":true}}],"security":"Class A ordinary shares","published_at":"2023-04-04T20:46:29.000Z","date":"2023-03-31","kind":"other","planned":false,"acquired":true,"shares":857500,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"See Exhibit 99.1"},{"field":"shares","element":"transactionShares","label":"F3","text":"See Exhibit 99.1"},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"See Exhibit 99.1"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"See Exhibit 99.1"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"See Exhibit 99.1"}],"balance_after":4050675,"source":{"system":"sec-edgar","filing":"0000899140-23-000514","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1869640/000089914023000514/form4.xml","form_type":"4"}},{"id":1928912,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":20922,"kind":"person","name":"Cowen Aaron","position":1,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"ten_percent_owner":true}}],"security":"Class A ordinary shares","published_at":"2023-04-04T20:46:29.000Z","date":"2023-03-31","kind":"other","planned":false,"acquired":false,"shares":3087000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"See Exhibit 99.1"},{"field":"shares","element":"transactionShares","label":"F1","text":"See Exhibit 99.1"},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"See Exhibit 99.1"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"See Exhibit 99.1"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"See Exhibit 99.1"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"See Exhibit 99.1"}],"balance_after":3193175,"source":{"system":"sec-edgar","filing":"0000899140-23-000514","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869640/000089914023000514/form4.xml","form_type":"4"}},{"id":2163279,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":20922,"kind":"person","name":"Cowen Aaron","position":1,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Ordinary Shares","published_at":"2022-09-08T20:48:07.000Z","date":"2022-09-06","kind":"purchase","acquired":true,"shares":7007,"price":6.99,"value":48978.93,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Notes are included on Exhibit 99.1."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Notes are included on Exhibit 99.1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Notes are included on Exhibit 99.1."}],"balance_after":6280175,"source":{"system":"sec-edgar","filing":"0001567619-22-017178","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869640/000156761922017178/doc1.xml","form_type":"4"}},{"id":2169125,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":20922,"kind":"person","name":"Cowen Aaron","position":1,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Ordinary Shares","published_at":"2022-09-01T16:46:00.000Z","date":"2022-08-31","kind":"purchase","acquired":true,"shares":2100,"price":8.94,"value":18774.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"See Exhibit 99.1"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"See Exhibit 99.1"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"See Exhibit 99.1"}],"balance_after":6273168,"source":{"system":"sec-edgar","filing":"0001567619-22-016896","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1869640/000156761922016896/doc1.xml","form_type":"4"}},{"id":2169124,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":20922,"kind":"person","name":"Cowen Aaron","position":1,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Ordinary Shares","published_at":"2022-09-01T16:46:00.000Z","date":"2022-08-31","kind":"purchase","acquired":true,"shares":1062,"price":8.93,"value":9483.66,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"See Exhibit 99.1"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"See Exhibit 99.1"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"See Exhibit 99.1"}],"balance_after":6271068,"source":{"system":"sec-edgar","filing":"0001567619-22-016896","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1869640/000156761922016896/doc1.xml","form_type":"4"}},{"id":2169123,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":20922,"kind":"person","name":"Cowen Aaron","position":1,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Ordinary Shares","published_at":"2022-09-01T16:46:00.000Z","date":"2022-08-30","kind":"purchase","acquired":true,"shares":706,"price":7.49,"value":5287.94,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"See Exhibit 99.1"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"See Exhibit 99.1"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"See Exhibit 99.1"}],"balance_after":6270006,"source":{"system":"sec-edgar","filing":"0001567619-22-016896","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869640/000156761922016896/doc1.xml","form_type":"4"}},{"id":2176271,"issuer":{"id":89130,"kind":"organization","name":"Akili, Inc.","symbol":"AKLI"},"owners":[{"id":124327,"kind":"organization","name":"SCS Sponsor I LLC","position":1,"cik":"0001850369","reported_name":"SCS Sponsor I LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director and 10% Owner"}},{"id":50611,"kind":"person","name":"Mehta Kishan","position":2,"cik":"0001850520","reported_name":"Mehta Kishan","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director and 10% Owner"}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":3,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director and 10% Owner"}},{"id":124328,"kind":"organization","name":"ChaChaCha DNA I, LLC","position":4,"cik":"0001869714","reported_name":"ChaChaCha DNA I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director and 10% Owner"}}],"security":"Class B ordinary shares","published_at":"2022-08-23T17:28:25.000Z","date":"2022-08-19","kind":"exercise","acquired":false,"shares":6220000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The Class B ordinary shares converted to Common Stock on a one-for-one basis upon the consummation of the Business Combination."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Class B ordinary shares converted to Common Stock on a one-for-one basis upon the consummation of the Business Combination."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Class B ordinary shares converted to Common Stock on a one-for-one basis upon the consummation of the Business Combination."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The Class B ordinary shares, par value $0.0001 per share (each a \"Class B ordinary share\"), held by the reporting owner, SCS Sponsor I LLC (the \"Sponsor\"), converted to the Issuer's common stock, par value $0.0001 per share (\"Common Stock\"), on a one-for-one basis upon the consummation of the business combination between the Issuer and Akili Interactive Labs, Inc. (the \"Business Combination\")."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The Sponsor is managed by its managers, Chamath Palihapitiya and Kishan Mehta.  A majority of the voting interests of the Sponsor are held by SC SPAC Holdings LLC, the successor by merger to ChaChaCha DNA I, LLC (\"SC SPAC Holdings\").  Messrs. Mehta and Cowen may be deemed to control the other member of the Sponsor.  Messrs. Mehta and Cowen and SC SPAC Holdings may be deemed to beneficially own shares held by the Sponsor by virtue of their direct or indirect interests in the Sponsor or their shared control over the Sponsor, as the case may be."}],"balance_after":0,"derivative":{"underlying":"Class A ordinary shares","underlying_shares":6220000},"source":{"system":"sec-edgar","filing":"0001209191-22-047241","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1869714/000120919122047241/doc4.xml","form_type":"4"}},{"id":2176270,"issuer":{"id":89130,"kind":"organization","name":"Akili, Inc.","symbol":"AKLI"},"owners":[{"id":124327,"kind":"organization","name":"SCS Sponsor I LLC","position":1,"cik":"0001850369","reported_name":"SCS Sponsor I LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director and 10% Owner"}},{"id":50611,"kind":"person","name":"Mehta Kishan","position":2,"cik":"0001850520","reported_name":"Mehta Kishan","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director and 10% Owner"}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":3,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director and 10% Owner"}},{"id":124328,"kind":"organization","name":"ChaChaCha DNA I, LLC","position":4,"cik":"0001869714","reported_name":"ChaChaCha DNA I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director and 10% Owner"}}],"security":"Common Stock","published_at":"2022-08-23T17:28:25.000Z","date":"2022-08-19","kind":"other","acquired":false,"shares":6860000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Represents the distribution for no consideration by the Sponsor of 6,860,000 shares of Common Stock to its members pro rata in accordance with their respective interests."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-22-047241","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1869714/000120919122047241/doc4.xml","form_type":"4"}},{"id":2176269,"issuer":{"id":89130,"kind":"organization","name":"Akili, Inc.","symbol":"AKLI"},"owners":[{"id":124327,"kind":"organization","name":"SCS Sponsor I LLC","position":1,"cik":"0001850369","reported_name":"SCS Sponsor I LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director and 10% Owner"}},{"id":50611,"kind":"person","name":"Mehta Kishan","position":2,"cik":"0001850520","reported_name":"Mehta Kishan","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director and 10% Owner"}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":3,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director and 10% Owner"}},{"id":124328,"kind":"organization","name":"ChaChaCha DNA I, LLC","position":4,"cik":"0001869714","reported_name":"ChaChaCha DNA I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director and 10% Owner"}}],"security":"Common Stock","published_at":"2022-08-23T17:28:25.000Z","date":"2022-08-19","kind":"exercise","acquired":true,"shares":6220000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The Class B ordinary shares, par value $0.0001 per share (each a \"Class B ordinary share\"), held by the reporting owner, SCS Sponsor I LLC (the \"Sponsor\"), converted to the Issuer's common stock, par value $0.0001 per share (\"Common Stock\"), on a one-for-one basis upon the consummation of the business combination between the Issuer and Akili Interactive Labs, Inc. (the \"Business Combination\")."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The Sponsor is managed by its managers, Chamath Palihapitiya and Kishan Mehta.  A majority of the voting interests of the Sponsor are held by SC SPAC Holdings LLC, the successor by merger to ChaChaCha DNA I, LLC (\"SC SPAC Holdings\").  Messrs. Mehta and Cowen may be deemed to control the other member of the Sponsor.  Messrs. Mehta and Cowen and SC SPAC Holdings may be deemed to beneficially own shares held by the Sponsor by virtue of their direct or indirect interests in the Sponsor or their shared control over the Sponsor, as the case may be."}],"balance_after":6860000,"source":{"system":"sec-edgar","filing":"0001209191-22-047241","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869714/000120919122047241/doc4.xml","form_type":"4"}},{"id":2208132,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":125414,"kind":"organization","name":"SCS Sponsor III LLC","position":1,"cik":"0001850379","reported_name":"SCS Sponsor III LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director and 10% Owner"}},{"id":50611,"kind":"person","name":"Mehta Kishan","position":2,"cik":"0001850520","reported_name":"Mehta Kishan","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director and 10% Owner"}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":3,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director and 10% Owner"}},{"id":125415,"kind":"organization","name":"ChaChaCha DNA III, LLC","position":4,"cik":"0001869713","reported_name":"ChaChaCha DNA III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director and 10% Owner"}}],"security":"Class B ordinary shares","published_at":"2022-07-13T16:25:30.000Z","date":"2022-07-11","kind":"exercise","acquired":false,"shares":6220000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The Class B ordinary shares were automatically convertible into Class A ordinary shares at the time of the issuer's initial business combination, or earlier at the option of the holder, on a one-for-one basis, subject to certain adjustments, and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Class B ordinary shares were automatically convertible into Class A ordinary shares at the time of the issuer's initial business combination, or earlier at the option of the holder, on a one-for-one basis, subject to certain adjustments, and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Class B ordinary shares were automatically convertible into Class A ordinary shares at the time of the issuer's initial business combination, or earlier at the option of the holder, on a one-for-one basis, subject to certain adjustments, and had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The Class B ordinary shares held by the reporting owner, SCS Sponsor III LLC (the \"Sponsor\"), converted to Class A ordinary shares on a one-for-one basis upon the consummation of the business combination between the issuer and ProKidney LP."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The Sponsor is managed by its managers, Chamath Palihapitiya and Kishan Mehta.  A majority of the voting interests of the Sponsor are held by SC SPAC Holdings LLC, the successor by merger to ChaChaCha DNA III, LLC (\"SC SPAC Holdings\").  Messrs. Mehta and Cowen may be deemed to control the other member of the Sponsor.  Messrs. Mehta and Cowen and SC SPAC Holdings may be deemed to beneficially own shares held by the Sponsor by virtue of their direct or indirect interests in the Sponsor or their shared control over the Sponsor, as the case may be."}],"balance_after":0,"derivative":{"underlying":"Class A ordinary shares","underlying_shares":6220000},"source":{"system":"sec-edgar","filing":"0001209191-22-042045","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1869713/000120919122042045/doc4.xml","form_type":"4"}},{"id":2208131,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":125414,"kind":"organization","name":"SCS Sponsor III LLC","position":1,"cik":"0001850379","reported_name":"SCS Sponsor III LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director and 10% Owner"}},{"id":50611,"kind":"person","name":"Mehta Kishan","position":2,"cik":"0001850520","reported_name":"Mehta Kishan","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director and 10% Owner"}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":3,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director and 10% Owner"}},{"id":125415,"kind":"organization","name":"ChaChaCha DNA III, LLC","position":4,"cik":"0001869713","reported_name":"ChaChaCha DNA III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director and 10% Owner"}}],"security":"Class A ordinary shares","published_at":"2022-07-13T16:25:30.000Z","date":"2022-07-11","kind":"other","acquired":false,"shares":6860000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Represents the distribution for no consideration by the Sponsor of 6,860,000 Class A ordinary shares to its members pro rata in accordance with their respective interests."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-22-042045","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1869713/000120919122042045/doc4.xml","form_type":"4"}},{"id":2208130,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":125414,"kind":"organization","name":"SCS Sponsor III LLC","position":1,"cik":"0001850379","reported_name":"SCS Sponsor III LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director and 10% Owner"}},{"id":50611,"kind":"person","name":"Mehta Kishan","position":2,"cik":"0001850520","reported_name":"Mehta Kishan","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director and 10% Owner"}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":3,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director and 10% Owner"}},{"id":125415,"kind":"organization","name":"ChaChaCha DNA III, LLC","position":4,"cik":"0001869713","reported_name":"ChaChaCha DNA III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director and 10% Owner"}}],"security":"Class A ordinary shares","published_at":"2022-07-13T16:25:30.000Z","date":"2022-07-11","kind":"exercise","acquired":true,"shares":6220000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The Class B ordinary shares held by the reporting owner, SCS Sponsor III LLC (the \"Sponsor\"), converted to Class A ordinary shares on a one-for-one basis upon the consummation of the business combination between the issuer and ProKidney LP."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The Sponsor is managed by its managers, Chamath Palihapitiya and Kishan Mehta.  A majority of the voting interests of the Sponsor are held by SC SPAC Holdings LLC, the successor by merger to ChaChaCha DNA III, LLC (\"SC SPAC Holdings\").  Messrs. Mehta and Cowen may be deemed to control the other member of the Sponsor.  Messrs. Mehta and Cowen and SC SPAC Holdings may be deemed to beneficially own shares held by the Sponsor by virtue of their direct or indirect interests in the Sponsor or their shared control over the Sponsor, as the case may be."}],"balance_after":6860000,"source":{"system":"sec-edgar","filing":"0001209191-22-042045","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869713/000120919122042045/doc4.xml","form_type":"4"}},{"id":2602530,"issuer":{"id":123913,"kind":"organization","name":"Social Capital Suvretta Holdings Corp. IV","symbol":"DNAD"},"owners":[{"id":136266,"kind":"person","name":"SCS Sponsor IV LLC","position":1,"cik":"0001850376","reported_name":"SCS Sponsor IV LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67963,"kind":"person","name":"Palihapitiya Chamath","position":2,"cik":"0001715450","reported_name":"Palihapitiya Chamath","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":50611,"kind":"person","name":"Mehta Kishan","position":3,"cik":"0001850520","reported_name":"Mehta Kishan","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President"}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":4,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":136267,"kind":"person","name":"ChaChaCha DNA IV, LLC","position":5,"cik":"0001869773","reported_name":"ChaChaCha DNA IV, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class B ordinary shares","published_at":"2021-08-16T18:34:22.000Z","date":"2021-08-16","kind":"disposition_to_issuer","acquired":false,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"As described in the issuer's registration statement on Form S-1 (File No. 333-256727) under the heading \"Description of Securities--Founder Shares,\" the Class B ordinary shares, par value $0.0001 per share, of the issuer will automatically convert into Class A ordinary shares, par value $0.0001 per share, of the issuer at the time of the issuer's initial business combination, or earlier at the option of the holder, on a one-for-one basis, subject to certain adjustment, and have no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On August 16, 2021, SCS Sponsor IV LLC forfeited at no cost 75,000 shares of Class B common stock of the issuer in connection with the election by the underwriters of the issuer's initial public offering to decline to exercise in full their option to purchase additional Class A ordinary shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"As described in the issuer's registration statement on Form S-1 (File No. 333-256727) under the heading \"Description of Securities--Founder Shares,\" the Class B ordinary shares, par value $0.0001 per share, of the issuer will automatically convert into Class A ordinary shares, par value $0.0001 per share, of the issuer at the time of the issuer's initial business combination, or earlier at the option of the holder, on a one-for-one basis, subject to certain adjustment, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"As described in the issuer's registration statement on Form S-1 (File No. 333-256727) under the heading \"Description of Securities--Founder Shares,\" the Class B ordinary shares, par value $0.0001 per share, of the issuer will automatically convert into Class A ordinary shares, par value $0.0001 per share, of the issuer at the time of the issuer's initial business combination, or earlier at the option of the holder, on a one-for-one basis, subject to certain adjustment, and have no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The reporting owner, SCS Sponsor IV LLC (the \"Sponsor\"), in whose name the securities reported herein are held, is managed by its managers, Chamath Palihapitiya and Kishan Mehta. A majority of the voting interests of the Sponsor are held by ChaChaCha DNA IV, LLC (\"ChaChaCha\"), which is controlled by Mr. Palihapitiya. Messrs. Mehta and Cowen may be deemed to control the other member of the Sponsor. Messrs. Palihapitiya, Mehta and Cowen and ChaChaCha may be deemed to beneficially own shares held by the Sponsor by virtue of their direct or indirect interests in the Sponsor or their shared control over the Sponsor, as the case may be. Each of Mr. Palihapitiya, Mr. Mehta, ChaChaCha and Mr. Cowen disclaims beneficial ownership of the shares held by the Sponsor, except to the extent of such person's pecuniary interest therein."}],"balance_after":6220000,"derivative":{"underlying":"Class A ordinary shares","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001209191-21-051683","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869773/000120919121051683/doc4.xml","form_type":"4"}},{"id":2602531,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":125414,"kind":"organization","name":"SCS Sponsor III LLC","position":1,"cik":"0001850379","reported_name":"SCS Sponsor III LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67963,"kind":"person","name":"Palihapitiya Chamath","position":2,"cik":"0001715450","reported_name":"Palihapitiya Chamath","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":50611,"kind":"person","name":"Mehta Kishan","position":3,"cik":"0001850520","reported_name":"Mehta Kishan","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President"}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":4,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":125415,"kind":"organization","name":"ChaChaCha DNA III, LLC","position":5,"cik":"0001869713","reported_name":"ChaChaCha DNA III, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class B ordinary shares","published_at":"2021-08-16T18:31:25.000Z","date":"2021-08-16","kind":"disposition_to_issuer","acquired":false,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"As described in the issuer's registration statement on Form S-1 (File No. 333-256725) under the heading \"Description of Securities--Founder Shares,\" the Class B ordinary shares, par value $0.0001 per share, of the issuer will automatically convert into Class A ordinary shares, par value $0.0001 per share, of the issuer at the time of the issuer's initial business combination, or earlier at the option of the holder, on a one-for-one basis, subject to certain adjustment, and have no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On August 16, 2021, SCS Sponsor III LLC forfeited at no cost 75,000 shares of Class B common stock of the issuer in connection with the election by the underwriters of the issuer's initial public offering to decline to exercise in full their option to purchase additional Class A ordinary shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"As described in the issuer's registration statement on Form S-1 (File No. 333-256725) under the heading \"Description of Securities--Founder Shares,\" the Class B ordinary shares, par value $0.0001 per share, of the issuer will automatically convert into Class A ordinary shares, par value $0.0001 per share, of the issuer at the time of the issuer's initial business combination, or earlier at the option of the holder, on a one-for-one basis, subject to certain adjustment, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"As described in the issuer's registration statement on Form S-1 (File No. 333-256725) under the heading \"Description of Securities--Founder Shares,\" the Class B ordinary shares, par value $0.0001 per share, of the issuer will automatically convert into Class A ordinary shares, par value $0.0001 per share, of the issuer at the time of the issuer's initial business combination, or earlier at the option of the holder, on a one-for-one basis, subject to certain adjustment, and have no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The reporting owner, SCS Sponsor III LLC (the \"Sponsor\"), in whose name the securities reported herein are held, is managed by its managers, Chamath Palihapitiya and Kishan Mehta. A majority of the voting interests of the Sponsor are held by ChaChaCha DNA III, LLC (\"ChaChaCha\"), which is controlled by Mr. Palihapitiya. Messrs. Mehta and Cowen may be deemed to control the other member of the Sponsor. Messrs. Palihapitiya, Mehta and Cowen and ChaChaCha may be deemed to beneficially own shares held by the Sponsor by virtue of their direct or indirect interests in the Sponsor or their shared control over the Sponsor, as the case may be. Each of Mr. Palihapitiya, Mr. Mehta, ChaChaCha and Mr. Cowen disclaims beneficial ownership of the shares held by the Sponsor, except to the extent of such person's pecuniary interest therein."}],"balance_after":6220000,"derivative":{"underlying":"Class A ordinary shares","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001209191-21-051681","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869713/000120919121051681/doc4.xml","form_type":"4"}},{"id":2602975,"issuer":{"id":125597,"kind":"organization","name":"Social Capital Suvretta Holdings Corp. II","symbol":"DNAB"},"owners":[{"id":136272,"kind":"person","name":"SCS Sponsor II LLC","position":1,"cik":"0001850373","reported_name":"SCS Sponsor II LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67963,"kind":"person","name":"Palihapitiya Chamath","position":2,"cik":"0001715450","reported_name":"Palihapitiya Chamath","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":50611,"kind":"person","name":"Mehta Kishan","position":3,"cik":"0001850520","reported_name":"Mehta Kishan","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President"}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":4,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":136273,"kind":"person","name":"ChaChaCha DNA II, LLC","position":5,"cik":"0001869716","reported_name":"ChaChaCha DNA II, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class B ordinary shares","published_at":"2021-08-16T18:28:29.000Z","date":"2021-08-16","kind":"disposition_to_issuer","acquired":false,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"As described in the issuer's registration statement on Form S-1 (File No. 333-256724) under the heading \"Description of Securities--Founder Shares,\" the Class B ordinary shares, par value $0.0001 per share, of the issuer will automatically convert into Class A ordinary shares, par value $0.0001 per share, of the issuer at the time of the issuer's initial business combination, or earlier at the option of the holder, on a one-for-one basis, subject to certain adjustment, and have no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On August 16, 2021, SCS Sponsor II LLC forfeited at no cost 75,000 shares of Class B ordinary shares of the issuer in connection with the election by the underwriters of the issuer's initial public offering to decline to exercise in full their option to purchase additional Class A ordinary shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"As described in the issuer's registration statement on Form S-1 (File No. 333-256724) under the heading \"Description of Securities--Founder Shares,\" the Class B ordinary shares, par value $0.0001 per share, of the issuer will automatically convert into Class A ordinary shares, par value $0.0001 per share, of the issuer at the time of the issuer's initial business combination, or earlier at the option of the holder, on a one-for-one basis, subject to certain adjustment, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"As described in the issuer's registration statement on Form S-1 (File No. 333-256724) under the heading \"Description of Securities--Founder Shares,\" the Class B ordinary shares, par value $0.0001 per share, of the issuer will automatically convert into Class A ordinary shares, par value $0.0001 per share, of the issuer at the time of the issuer's initial business combination, or earlier at the option of the holder, on a one-for-one basis, subject to certain adjustment, and have no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The reporting owner, SCS Sponsor II LLC (the \"Sponsor\"), in whose name the securities reported herein are held, is managed by its managers, Chamath Palihapitiya and Kishan Mehta. A majority of the voting interests of the Sponsor are held by ChaChaCha DNA II, LLC (\"ChaChaCha\"), which is controlled by Mr. Palihapitiya. Messrs. Mehta and Cowen may be deemed to control the other member of the Sponsor. Messrs. Palihapitiya, Mehta and Cowen and ChaChaCha may be deemed to beneficially own shares held by the Sponsor by virtue of their direct or indirect interests in the Sponsor or their shared control over the Sponsor, as the case may be. Each of Mr. Palihapitiya, Mr. Mehta, ChaChaCha and Mr. Cowen disclaims beneficial ownership of the shares held by the Sponsor, except to the extent of such person's pecuniary interest therein."}],"balance_after":6220000,"derivative":{"underlying":"Class A ordinary shares","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001209191-21-051677","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869716/000120919121051677/doc4.xml","form_type":"4"}},{"id":2602529,"issuer":{"id":89130,"kind":"organization","name":"Akili, Inc.","symbol":"AKLI"},"owners":[{"id":124327,"kind":"organization","name":"SCS Sponsor I LLC","position":1,"cik":"0001850369","reported_name":"SCS Sponsor I LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67963,"kind":"person","name":"Palihapitiya Chamath","position":2,"cik":"0001715450","reported_name":"Palihapitiya Chamath","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":50611,"kind":"person","name":"Mehta Kishan","position":3,"cik":"0001850520","reported_name":"Mehta Kishan","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President"}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":4,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124328,"kind":"organization","name":"ChaChaCha DNA I, LLC","position":5,"cik":"0001869714","reported_name":"ChaChaCha DNA I, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class B ordinary shares","published_at":"2021-08-16T18:25:33.000Z","date":"2021-08-16","kind":"disposition_to_issuer","acquired":false,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"As described in the issuer's registration statement on Form S-1 (File No. 333-256723) under the heading \"Description of Securities--Founder Shares,\" the Class B ordinary shares, par value $0.0001 per share, of the issuer will automatically convert into Class A ordinary shares, par value $0.0001 per share, of the issuer at the time of the issuer's initial business combination, or earlier at the option of the holder, on a one-for-one basis, subject to certain adjustment, and have no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On August 16, 2021, SCS Sponsor I LLC forfeited at no cost 75,000 shares of Class B ordinary shares of the issuer in connection with the election by the underwriters of the issuer's initial public offering to decline to exercise in full their option to purchase additional Class A ordinary shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"As described in the issuer's registration statement on Form S-1 (File No. 333-256723) under the heading \"Description of Securities--Founder Shares,\" the Class B ordinary shares, par value $0.0001 per share, of the issuer will automatically convert into Class A ordinary shares, par value $0.0001 per share, of the issuer at the time of the issuer's initial business combination, or earlier at the option of the holder, on a one-for-one basis, subject to certain adjustment, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"As described in the issuer's registration statement on Form S-1 (File No. 333-256723) under the heading \"Description of Securities--Founder Shares,\" the Class B ordinary shares, par value $0.0001 per share, of the issuer will automatically convert into Class A ordinary shares, par value $0.0001 per share, of the issuer at the time of the issuer's initial business combination, or earlier at the option of the holder, on a one-for-one basis, subject to certain adjustment, and have no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The reporting owner, SCS Sponsor I LLC (the \"Sponsor\"), in whose name the securities reported herein are held, is managed by its managers, Chamath Palihapitiya and Kishan Mehta. A majority of the voting interests of the Sponsor are held by ChaChaCha DNA I, LLC (\"ChaChaCha\"), which is controlled by Mr. Palihapitiya. Messrs. Mehta and Cowen may be deemed to control the other member of the Sponsor. Messrs. Palihapitiya, Mehta and Cowen and ChaChaCha may be deemed to beneficially own shares held by the Sponsor by virtue of their direct or indirect interests in the Sponsor or their shared control over the Sponsor, as the case may be. Each of Mr. Palihapitiya, Mr. Mehta, ChaChaCha and Mr. Cowen disclaims beneficial ownership of the shares held by the Sponsor, except to the extent of such person's pecuniary interest therein."}],"balance_after":6220000,"derivative":{"underlying":"Class A ordinary shares","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001209191-21-051674","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869714/000120919121051674/doc4.xml","form_type":"4"}},{"id":2639764,"issuer":{"id":123913,"kind":"organization","name":"Social Capital Suvretta Holdings Corp. IV","symbol":"DNAD"},"owners":[{"id":136266,"kind":"person","name":"SCS Sponsor IV LLC","position":1,"cik":"0001850376","reported_name":"SCS Sponsor IV LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67963,"kind":"person","name":"Palihapitiya Chamath","position":2,"cik":"0001715450","reported_name":"Palihapitiya Chamath","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":50611,"kind":"person","name":"Mehta Kishan","position":3,"cik":"0001850520","reported_name":"Mehta Kishan","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President"}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":4,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":136267,"kind":"person","name":"ChaChaCha DNA IV, LLC","position":5,"cik":"0001869773","reported_name":"ChaChaCha DNA IV, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A ordinary shares","published_at":"2021-07-07T20:56:37.000Z","date":"2021-07-02","kind":"grant","acquired":true,"shares":640000,"price":10,"value":6400000.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reporting owner, SCS Sponsor IV LLC (the \"Sponsor\"), in whose name the securities reported herein are held, is managed by its managers, Chamath Palihapitiya and Kishan Mehta. A majority of the voting interests of the Sponsor are held by ChaChaCha DNA IV, LLC (\"ChaChaCha\"), which is controlled by Mr. Palihapitiya. Messrs. Mehta and Cowen may be deemed to control the other member of the Sponsor. Messrs. Palihapitiya, Mehta and Cowen and ChaChaCha may be deemed to beneficially own shares held by the Sponsor by virtue of their direct or indirect interests in the Sponsor or their shared control over the Sponsor, as the case may be. Each of Mr. Palihapitiya, Mr. Mehta, ChaChaCha and Mr. Cowen disclaims beneficial ownership of the shares held by the Sponsor, except to the extent of such person's pecuniary interest therein."}],"balance_after":640000,"source":{"system":"sec-edgar","filing":"0001209191-21-045954","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869773/000120919121045954/doc4.xml","form_type":"4"}},{"id":2639776,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":125414,"kind":"organization","name":"SCS Sponsor III LLC","position":1,"cik":"0001850379","reported_name":"SCS Sponsor III LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67963,"kind":"person","name":"Palihapitiya Chamath","position":2,"cik":"0001715450","reported_name":"Palihapitiya Chamath","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":50611,"kind":"person","name":"Mehta Kishan","position":3,"cik":"0001850520","reported_name":"Mehta Kishan","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President"}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":4,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":125415,"kind":"organization","name":"ChaChaCha DNA III, LLC","position":5,"cik":"0001869713","reported_name":"ChaChaCha DNA III, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A ordinary shares","published_at":"2021-07-07T20:52:12.000Z","date":"2021-07-02","kind":"grant","acquired":true,"shares":640000,"price":10,"value":6400000.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reporting owner, SCS Sponsor III LLC (the \"Sponsor\"), in whose name the securities reported herein are held, is managed by its managers,\nChamath Palihapitiya and Kishan Mehta. A majority of the voting interests of the Sponsor are held by ChaChaCha DNA III, LLC (\"ChaChaCha\"),\nwhich is controlled by Mr. Palihapitiya. Messrs. Mehta and Cowen may be deemed to control the other member of the Sponsor. Messrs. Palihapitiya, Mehta and Cowen and ChaChaCha may be deemed to beneficially own shares held by the Sponsor by virtue of their direct or indirect interests in the Sponsor or their shared control over the Sponsor, as the case may be. Each of Mr. Palihapitiya, Mr. Mehta, ChaChaCha and Mr. Cowen disclaims beneficial ownership of the shares held by the Sponsor, except to the extent of such person's pecuniary interest therein."}],"balance_after":640000,"source":{"system":"sec-edgar","filing":"0001209191-21-045953","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869713/000120919121045953/doc4.xml","form_type":"4"}},{"id":2640119,"issuer":{"id":125597,"kind":"organization","name":"Social Capital Suvretta Holdings Corp. II","symbol":"DNAB"},"owners":[{"id":136272,"kind":"person","name":"SCS Sponsor II LLC","position":1,"cik":"0001850373","reported_name":"SCS Sponsor II LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67963,"kind":"person","name":"Palihapitiya Chamath","position":2,"cik":"0001715450","reported_name":"Palihapitiya Chamath","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":50611,"kind":"person","name":"Mehta Kishan","position":3,"cik":"0001850520","reported_name":"Mehta Kishan","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President"}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":4,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":136273,"kind":"person","name":"ChaChaCha DNA II, LLC","position":5,"cik":"0001869716","reported_name":"ChaChaCha DNA II, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A ordinary shares","published_at":"2021-07-07T20:47:35.000Z","date":"2021-07-02","kind":"grant","acquired":true,"shares":640000,"price":10,"value":6400000.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reporting owner, SCS Sponsor II LLC (the \"Sponsor\"), in whose name the securities reported herein are held, is managed by its managers, Chamath Palihapitiya and Kishan Mehta. A majority of the voting interests of the Sponsor are held by ChaChaCha DNA II, LLC (\"ChaChaCha\"), which is controlled by Mr. Palihapitiya. Messrs. Mehta and Cowen may be deemed to control the other member of the Sponsor. Messrs. Palihapitiya, Mehta and Cowen and ChaChaCha may be deemed to beneficially own shares held by the Sponsor by virtue of their direct or indirect interests in the Sponsor or their shared control over the Sponsor, as the case may be. Each of Mr. Palihapitiya, Mr. Mehta, ChaChaCha and Mr. Cowen disclaims beneficial ownership of the shares held by the Sponsor, except to the extent of such person's pecuniary interest therein."}],"balance_after":640000,"source":{"system":"sec-edgar","filing":"0001209191-21-045951","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869716/000120919121045951/doc4.xml","form_type":"4"}},{"id":2639767,"issuer":{"id":89130,"kind":"organization","name":"Akili, Inc.","symbol":"AKLI"},"owners":[{"id":124327,"kind":"organization","name":"SCS Sponsor I LLC","position":1,"cik":"0001850369","reported_name":"SCS Sponsor I LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67963,"kind":"person","name":"Palihapitiya Chamath","position":2,"cik":"0001715450","reported_name":"Palihapitiya Chamath","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":50611,"kind":"person","name":"Mehta Kishan","position":3,"cik":"0001850520","reported_name":"Mehta Kishan","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President"}},{"id":20922,"kind":"person","name":"Cowen Aaron","position":4,"cik":"0001869640","reported_name":"Cowen Aaron","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124328,"kind":"organization","name":"ChaChaCha DNA I, LLC","position":5,"cik":"0001869714","reported_name":"ChaChaCha DNA I, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A ordinary shares","published_at":"2021-07-07T20:42:58.000Z","date":"2021-07-02","kind":"grant","acquired":true,"shares":640000,"price":10,"value":6400000.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reporting owner, SCS Sponsor I LLC (the \"Sponsor\"), in whose name the securities reported herein are held, is managed by its managers, Chamath Palihapitiya and Kishan Mehta. A majority of the voting interests of the Sponsor are held by ChaChaCha DNA I, LLC (\"ChaChaCha\"), which is controlled by Mr. Palihapitiya. Messrs. Mehta and Cowen may be deemed to control the other member of the Sponsor. Messrs. Palihapitiya, Mehta and Cowen and ChaChaCha may be deemed to beneficially own shares held by the Sponsor by virtue of their direct or indirect interests in the Sponsor or their shared control over the Sponsor, as the case may be. Each of Mr. Palihapitiya, Mr. Mehta, ChaChaCha and Mr. Cowen disclaims beneficial ownership of the shares held by the Sponsor, except to the extent of such person's pecuniary interest therein."}],"balance_after":640000,"source":{"system":"sec-edgar","filing":"0001209191-21-045949","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869714/000120919121045949/doc4.xml","form_type":"4"}}]}